Baupost Group
GOSS icon

Baupost Group’s Gossamer Bio GOSS Stock Holding History

Baupost Group’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-12,090
Closed -$15.9M – 33
2019
Q3 		$15.9M Sell
12,090
-3,750
-24% -$5.97M 0.18% 31
2019
Q2 		$27.3M Hold
15,840
– – 0.25% 30
2019
Q1 		$26.1M Buy
+15,840
New +$26.4M 0.22% 33

Other funds holding GOSS

OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
HHLR Advisors
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Boxer Capital
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Baupost Group's GOSS Position: Q4 2019 in Review

Baupost Group sold out of Gossamer Bio (GOSS) in Q4 2019, closing a stake of 12,090 shares — an estimated $15.9M sold.

Baupost Group first reported a position in GOSS in Q1 2019 and held it in 3 quarters. The position peaked at $27.3M in Q2 2019. 86 funds tracked by Wall St. Rank hold GOSS as of Q4 2019.

  • Baupost Group reported no remaining Gossamer Bio position as of Q4 2019 after selling out during the quarter.
  • Baupost Group sold 12,090 Gossamer Bio shares in Q4 2019, an estimated $15.9M.
  • Baupost Group first reported a position in Gossamer Bio in Q1 2019 and held it in 3 quarters.
  • Baupost Group's Gossamer Bio position peaked at $27.3M in Q2 2019.
  • 86 funds tracked by Wall St. Rank held Gossamer Bio as of Q4 2019.

Based on Baupost Group's 13F filing for Q4 2019, filed 13 Feb 2020.